Selective activity over a constitutively active RET‐variant of the oral multikinase inhibitor dovitinib: Results of the CNIO‐BR002 phase I‐trial
暂无分享,去创建一个
R. Salazar | M. J. Bueno | L. Lombardía | R. Colomer | M. Gil | R. Márquez | E. Tan | J. Guerra | M. Quintela-Fandino | A. Lopez | A. González-Martín | R. Bratos